KALA BIO, Inc. Quarterly Debt-to-equity in % from Q1 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
KALA BIO, Inc. quarterly Debt-to-equity history and growth rate from Q1 2018 to Q3 2024.
  • KALA BIO, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 547 %, a 80.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 547 +244 +80.5% Sep 30, 2024
Q2 2024 493 +64.6 +15.1% Jun 30, 2024
Q1 2024 452 -2.77K -86% Mar 31, 2024
Q4 2023 329 +2.39K Dec 31, 2023
Q3 2023 303 +2.41K Sep 30, 2023
Q2 2023 428 -751 -63.7% Jun 30, 2023
Q1 2023 3.23K +2.91K +909% Mar 31, 2023
Q4 2022 -2.06K -2.25K -1208% Dec 31, 2022
Q3 2022 -2.11K -2.25K -1583% Sep 30, 2022
Q2 2022 1.18K +1.06K +859% Jun 30, 2022
Q1 2022 320 +213 +198% Mar 31, 2022
Q4 2021 186 +86.3 +86.7% Dec 31, 2021
Q3 2021 142 +24.6 +20.9% Sep 30, 2021
Q2 2021 123 -15.8 -11.4% Jun 30, 2021
Q1 2021 107 -66.1 -38.1% Mar 31, 2021
Q4 2020 99.5 -120 -54.7% Dec 31, 2020
Q3 2020 118 -42.5 -26.6% Sep 30, 2020
Q2 2020 139 +14.3 +11.5% Jun 30, 2020
Q1 2020 173 +80.8 +87.3% Mar 31, 2020
Q4 2019 220 +156 +243% Dec 31, 2019
Q3 2019 160 +123 +333% Sep 30, 2019
Q2 2019 124 +93.6 +304% Jun 30, 2019
Q1 2019 92.6 +34.3 +58.9% Mar 31, 2019
Q4 2018 64 Dec 31, 2018
Q3 2018 36.9 Sep 30, 2018
Q2 2018 30.8 Jun 30, 2018
Q1 2018 58.3 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.